Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
DINO RCT - Treating Anxiety in Children With Autism
for
Autism Spectrum Disorder, Anxiety Disorders
Location: Baltimore MD
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Sex: All
Age: 4 - 6
Code: NCT06066983
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
for
HIV Infections, Substance Use Disorders, Addiction, Opioid Use,
Location: Frederick MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT06103370
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Waterford CT, Springfield MA, Westbury NY, Oceanside NY,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase 2, Recruiting
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
for
Lyme Disease
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 13 - 70+
Code: NCT00001539
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07008118
Phase 1, Recruiting
Alleviant ALLAY-HF Study
for
Heart Failure
Location: Boston MA, Stony Brook NY, Montreal, New York NY,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 40+
Code: NCT05685303
Recruiting
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Providence RI, New Haven CT, Lebanon NH, Bay Shore NY,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Halifax, Boston MA, New Haven CT, Quebec, Manhasset NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
for
Endothelial Dysfunction,
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 18 - 70+
Code: NCT03253705
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
Intent of Surgery for IPMN
for
Intraductal Papillary Mucinous Neoplasm
Location: Boston MA, New York NY, Baltimore MD, Durham NC,
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT07216521
Recruiting
Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia
Location: Bethesda MD, Charlottesville VA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06965114
Phase 1, Phase 2, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue